APOE and Down syndrome: Notably, Aβ1–42/1–40 levels in cerebrospinal fluid decreased, hippocampi shortened, plaque burdens increased, cortical metabolism slowed, and plasma phospho-tau181 levels rose sooner in individuals with Down’s syndrome and ApoE4 [24,76].